Shenyang Xingqi PharmaceuticalLtds five-year total shareholder returns outpace the underlying earnings growth - Simply Wall St

300293 Stock   22.72  0.97  4.09%   
About 62% of Shenyang Blue's investor base is looking to short. The analysis of overall sentiment of trading Shenyang Blue Silver stock suggests that many investors are alarmed at this time. The current market sentiment, together with Shenyang Blue's historical and current headlines, can help investors time the market. In addition, many technical investors use Shenyang Blue Silver stock news signals to limit their universe of possible portfolio assets.
  
Shenyang Xingqi PharmaceuticalLtds five-year total shareholder returns outpace the underlying earnings growth Simply Wall St

Read at news.google.com
Google News at Macroaxis
  

Shenyang Blue Fundamental Analysis

We analyze Shenyang Blue's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shenyang Blue using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shenyang Blue based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Profit Margin

Profit Margin Comparative Analysis

Shenyang Blue is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Shenyang Blue Silver Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Shenyang Blue stock to make a market-neutral strategy. Peer analysis of Shenyang Blue could also be used in its relative valuation, which is a method of valuing Shenyang Blue by comparing valuation metrics with similar companies.

Peers

Shenyang Blue Related Equities

688617APT Medical   2.67   
0%
68.0%
600519Kweichow Moutai   0.07   
1.0%
0%
300750Contemporary Amperex   0.22   
5.0%
0%
002594BYD Co   0.82   
20.0%
0%
300760Shenzhen Mindray   1.46   
37.0%
0%
688169Beijing Roborock   1.52   
38.0%
0%
688298Zhejiang Orient   2.88   
73.0%
0%
688111Beijing Kingsoft   3.05   
77.0%
0%
002371NAURA Technology   3.92   
100.0%
0%

Complementary Tools for Shenyang Stock analysis

When running Shenyang Blue's price analysis, check to measure Shenyang Blue's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shenyang Blue is operating at the current time. Most of Shenyang Blue's value examination focuses on studying past and present price action to predict the probability of Shenyang Blue's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shenyang Blue's price. Additionally, you may evaluate how the addition of Shenyang Blue to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data